EPIOXA Trademark

Trademark Overview

On Wednesday, March 23, 2022, a trademark application was filed for EPIOXA with the United States Patent and Trademark Office. The USPTO has given the EPIOXA trademark a serial number of 97327082. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by Glaukos Corporation. The EPIOXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of eye conditions and diseases
epioxa

General Information

Serial Number97327082
Word MarkEPIOXA
Filing DateWednesday, March 23, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of eye conditions and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaukos Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672
Party NameGlaukos Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672

Trademark Events

Event DateEvent Description
Saturday, March 26, 2022NEW APPLICATION ENTERED
Tuesday, March 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023ASSIGNED TO EXAMINER
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 1 FILED
Monday, September 18, 2023SOU EXTENSION 1 GRANTED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU EXTENSION 3 GRANTED
Wednesday, September 11, 2024SOU EXTENSION 3 FILED

Related Keywords

epioxa diseases conditions treatment preparations pharmaceutical